{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:00:12Z","timestamp":1787014812527,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4053,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1111\/j.1523-1755.2004.00952.x","type":"journal-article","created":{"date-parts":[[2004,10,19]],"date-time":"2004-10-19T14:58:41Z","timestamp":1098197921000},"page":"1766-1773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats"],"prefix":"10.1016","volume":"66","author":[{"given":"Vicente E.","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William E.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis D.","family":"Avner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0010","series-title":"Pediatric Nephrology","first-page":"675","author":"Dell","year":"2004"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s001090050221","article-title":"Autosomal recessive polycystic kidney disease","volume":"76","author":"Zerres","year":"1998","journal-title":"J Mol Med"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0020","series-title":"GeneClinics GeneReviews; Genetic Disease Online Reviews at GeneTests-GeneClinics","article-title":"Autosomal recessive polycystic kidney disease","author":"Dell","year":"2001"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s004670050281","article-title":"Autosomal recessive polycstic kidney disease: Long term outcome of neonatal survivors","volume":"11","author":"Roy","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/snep.2001.20929","article-title":"The genetics and physiology of polycystic kidney disease","volume":"21","author":"Calvet","year":"2001","journal-title":"Semin Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/snep.2001.24937","article-title":"Can progression of autosomal dominant or autosomal recessive polycystic kidney disease be prevented?","volume":"21","author":"Davis","year":"2001","journal-title":"Semin Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0040","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1046\/j.1523-1755.2001.00716.x","article-title":"Treatment prospects for autosomal dominant polycystic kidney disease","volume":"59","author":"Qian","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0045","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1097\/01.ASN.0000028643.17901.42","article-title":"Genetics and pathogenesis of polycystic kidney disease","volume":"13","author":"Igarashi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein","volume":"30","author":"Ward","year":"2002","journal-title":"Nature Genet"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0055","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/340448","article-title":"PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats","volume":"70","author":"Onuchic","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1523-1755.2001.00473.x","article-title":"The pck rat: A new model that resembles human autosomal dominant polycystic kidney and liver disease","volume":"59","author":"Lager","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0065","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0002-9440(10)64116-8","article-title":"Polycystic kidney rat is a novel animal model of Caroli's disease associated with congenital hepatic fibrosis","volume":"158","author":"Sanzen","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ki.1995.62","article-title":"Epidermal growth factor receptor expression is abnormal in murine polycystic kidney","volume":"47","author":"Orellana","year":"1995","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0075","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI2071","article-title":"Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease","volume":"101","author":"Richards","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0080","first-page":"F387","article-title":"Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease","volume":"275","author":"Sweeney","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0085","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1523-1755.1999.00577.x","article-title":"In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor","volume":"56","author":"Sweeney","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1523-1755.2000.00829.x","article-title":"Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor","volume":"57","author":"Sweeney","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0095","first-page":"1843","article-title":"Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts","volume":"3","author":"Grantham","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0100","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/ki.1996.230","article-title":"Mechanisms of fluid secretion by polycystic epithelia","volume":"49","author":"Sullivan","year":"1996","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0105","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2000.00991.x","article-title":"cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway","volume":"57","author":"Yamaguchi","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0110","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1523-1755.2001.060002484.x","article-title":"Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells","volume":"60","author":"Sutters","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0115","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0120","doi-asserted-by":"crossref","first-page":"C693","DOI":"10.1152\/ajpcell.00122.2001","article-title":"cAMP-dependent protein kinase and proliferation differ in normal and polycystic kidney epithelia","volume":"282","author":"Marfella-Scivittaro","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nature Med"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0130","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nature Med"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","article-title":"Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease","volume":"24","author":"Gattone","year":"1999","journal-title":"Develop Gen"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0140","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1046\/j.1523-1755.2003.00256.x","article-title":"EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats","volume":"64","author":"Torres","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0145","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1046\/j.1523-1755.2001.00963.x","article-title":"A novel inhibitor of tumor necrosis factor-alpha converting enzyme ameliorates polycystic kidney disease","volume":"60","author":"Dell","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0150","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1046\/j.1523-1755.2003.00232.x","article-title":"Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability","volume":"64","author":"Sweeney","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0155","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0006-2952(98)00356-6","article-title":"Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)","volume":"57","author":"Discafani","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0160","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/79534","article-title":"Combinatorial chemoprevention of intestinal neoplasia","volume":"6","author":"Torrance","year":"2000","journal-title":"Nature Med"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0165","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0272-6386(97)90496-0","article-title":"Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease","volume":"30","author":"Yamaguchi","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0170","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1152\/jappl.2000.88.4.1316","article-title":"Renal vasopressin receptor expression and function in rats following spaceflight","volume":"88","author":"Brooks","year":"2000","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0272-6386(12)80212-5","article-title":"Epidermal growth factor and endothelin in cyst fluid from autosomal dominant polycystic kidney disease cases: Possible evidence of heterogeneity in cystogenesis","volume":"24","author":"Munemura","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0180","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0022-5347(01)67652-3","article-title":"Epidermal growth factor precursor is present in a variety of human renal cyst fluids","volume":"153","author":"Moskowitz","year":"1995","journal-title":"J Urol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0012-1606(90)90192-L","article-title":"Defective epidermal growth factor gene expression in mice with polycystic kidney disease","volume":"138","author":"Gattone","year":"1990","journal-title":"Develop Biol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ki.1991.7","article-title":"Epidermal growth factor (EGF) expression in the congenital polycystic mouse kidney","volume":"39","author":"Horikoshi","year":"1991","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0195","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1681\/ASN.V371378","article-title":"Growth factor gene expression in kidney of murine polycystic kidney disease","volume":"3","author":"Nakamura","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0200","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1681\/ASN.V661679","article-title":"Abnormal expression of epidermal growth factor and sulfated glycoprotein SGP-2 messenger RNA in a rat model of autosomal dominant polycystic kidney diseas","volume":"6","author":"Cowley","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0272-6386(12)70198-1","article-title":"Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma","volume":"19","author":"Klingel","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-5347(01)64084-9","article-title":"Expression of transforming growth factor \u03b1 and epidermal growth factor receptor in adult polycystic kidney disease","volume":"159","author":"Lee","year":"1998","journal-title":"J Urol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0215","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/ki.1992.184","article-title":"In vitro formation and expansion of cysts derived from human renal cortex epithelial cells","volume":"41","author":"Neufeld","year":"1992","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0220","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/ki.1995.118","article-title":"Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture","volume":"47","author":"Pugh","year":"1995","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0225","first-page":"386","article-title":"Renal cysts in transgenic mice expressing transforming growth factor-\u03b1","volume":"124","author":"Lowden","year":"1994","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0230","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1083\/jcb.122.1.199","article-title":"An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice","volume":"122","author":"Stocklin","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0235","first-page":"1051","article-title":"Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys","volume":"142","author":"Schaffner","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0240","doi-asserted-by":"crossref","first-page":"C487","DOI":"10.1152\/ajpcell.1995.269.2.C487","article-title":"Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD","volume":"269","author":"Du","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0245","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1681\/ASN.V122379","article-title":"Segment-specific c-ErbB2 expression in human autosomal recessive polycystic kidney disease","volume":"12","author":"Nakanishi","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0250","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1097-4652(199801)174:1<9::AID-JCP2>3.0.CO;2-S","article-title":"Epidermal growth factor (EGF) receptor density controls mitogenic activation of normal rat kidney (NRK) cells by EGF","volume":"174","author":"Lahaye","year":"1998","journal-title":"J Cell Physiol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0255","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s004670000495","article-title":"Renal dysfunction but not cystic change is ameliorated by neonatal epidermal growth factor in bpk mice","volume":"16","author":"Nakanishi","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0260","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/dbio.1995.1164","article-title":"Epidermal growth factor ameliorates autosomal recessive polycystic kidney disease in mice","volume":"169","author":"Gattone","year":"1995","journal-title":"Develop Biol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0265","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1357-2725(99)00015-1","article-title":"EGF receptor","volume":"31","author":"Wells","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0270","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1074\/jbc.271.12.6947","article-title":"Activation of Gs alpha by the epidermal growth factor receptor involves phosphorylation","volume":"271","author":"Poppleton","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0275","doi-asserted-by":"crossref","first-page":"31098","DOI":"10.1074\/jbc.271.49.31098","article-title":"Tyrosine phosphorylation of GS\u03b1 and inhibition of bradykinin-induced activation of the cyclic AMP pathway in A431 cells by epidermal growth factor receptor","volume":"271","author":"Liebmann","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0280","first-page":"F956","article-title":"Effects of calcium on the vasopressin-sensitive cAMP metabolism in medullary tubules","volume":"249","author":"Kusano","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0285","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/sj.bjp.0702390","article-title":"Cell-specific coupling of PGE2 to different transduction pathways in arginine vasopressin- and glucagon-sensitive segments of the rat renal tubule","volume":"126","author":"Aarab","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0290","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0898-6568(99)00031-5","article-title":"Functional properties of Ca2+-inhibitable type 5 and type 6 adenylyl cyclases and role of Ca2+ increase in the inhibition of intracellular cAMP content","volume":"11","author":"Chabardes","year":"1999","journal-title":"Cell Signal"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0295","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1172\/JCI113732","article-title":"Epidermal growth factor inhibits the hydro-osmotic effect of vasopressin in the isolated perfused rabbit cortical collecting tubule","volume":"82","author":"Breyer","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2004.00952.x_bb0300","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1046\/j.1471-4159.1995.65041597.x","article-title":"Potentiation of agonist-stimulated cyclic AMP accumulation by tyrosine kinase inhibitors in rat pinealocytes","volume":"65","author":"Ho","year":"1995","journal-title":"J Neurochem"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815502664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815502664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:42:43Z","timestamp":1758760963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815502664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0085253815502664"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00952.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00952.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}